Rho iso-alpha acids from hops inhibit the GSK-3/NF-B pathway and reduce inflammatory markers associated with bone and cartilage degradation

Journal of Inflammation

Volumn 6, Issue , 2009, Pages

  Konda, Veera Reddy ^a   Desai, Anuradha ^a   Darland, Gary ^a   Bland, Jeffrey S ^a   Tripp, Matthew L ^a  

^a Metagenics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; CELECOXIB; COLLAGENASE 3; GLYCOGEN SYNTHASE KINASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN INHIBITOR; RHO ISO ALPHA ACID DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE; THROMBIN RECEPTOR ACTIVATING PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; BONE DEFECT; CARTILAGE DEGENERATION; CHONDROSARCOMA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; JOINT SWELLING; MACROPHAGE; MOUSE; NONHUMAN; OSTEOCLAST; PROTEIN BINDING; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYMPTOM; WESTERN BLOTTING;

HUMULUS; MUS;

EID: 70349251325     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-6-26     Document Type: Article

References (29)

1. LPS induction of gene expression in human monocytes. M Guha N Mackman, Cell Signal 2001 13 85 94 10.1016/S0898-6568(00)00149-2 11257452
2. Glycogen synthase kinase-3beta inhibition attenuates the degree of arthritis caused by type II collagen in the mouse. S Cuzzocrea E Mazzon R Di Paola C Muia C Crisafulli L Dugo M Collin D Britti AP Caputi C Thiemermann, Clin Immunol 2006 120 57 67 10.1016/j.clim.2006.03.005 16631408
3. Hepatocyte growth factor suppresses proinflammatory NFkappaB activation through GSK3beta inactivation in renal tubular epithelial cells. R Gong A Rifai Y Ge S Chen LD Dworkin, J Biol Chem 2008 283 7401 7410 10.1074/jbc.M710396200 18201972
4. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. AA Beg WC Sha RT Bronson S Ghosh D Baltimore, Nature 1995 376 167 170 10.1038/376167a0 7603567
5. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. KP Hoeflich J Luo EA Rubie MS Tsao O Jin JR Woodgett, Nature 2000 406 86 90 10.1038/35017574 10894547
6. Safety, efficacy and anti-inflammatory activity of rho iso-alpha-acids from hops. AJ Hall JG Babish GK Darland BJ Carroll VR Konda RH Lerman JS Bland ML Tripp, Phytochemistry 2008 69 1534 1547 10.1016/j.phytochem.2008.02.001 18358504
7. Hop and modified hop extracts have potent in vitro anti-inflammatory properties. M Tripp G Darland R Lerman D Lukaczer J Bland J Babish, Acta Hort (ISHS) 2005 668 217 228
8. Clinical safety and efficacy of NG440: a novel combination of rho iso-alpha acids from hops, rosemary, and oleanolic acid for inflammatory conditions. DM Minich JS Bland J Katke G Darland A Hall RH Lerman J Lamb B Carroll M Tripp, Can J Physiol Pharmacol 2007 85 872 883 10.1139/Y07-055 18066133
9. 5-lipoxygenase-activating protein gene expression. Key role of CCAAT/enhancer-binding proteins (C/EBP) in constitutive and tumor necrosis factor (TNF) alpha-induced expression in THP-1 cells. KV Reddy KJ Serio CR Hodulik TD Bigby, J Biol Chem 2003 278 13810 13818 10.1074/jbc.M211102200 12571239
10. META060 inhibits multiple kinases in the NF-kappaB pathway and suppresses LPS - mediated inflammation in vitro and ex vivo. A Desai VR Konda G Darland M Austin KS Prabhu JS Bland BJ Carroll ML Tripp, Inflamm Res 2009 58 229 234 10.1007/s00011-008-8162-y 19169645
11. A novel class of antioxidants inhibit LPS induction of tissue factor by selective inhibition of the activation of ASK1 and MAP kinases. JP Luyendyk JD Piper M Tencati KV Reddy T Holscher R Zhang J Luchoomun X Chen W Min C Kunsch N Mackman, Arterioscler Thromb Vasc Biol 2007 27 1857 1863 10.1161/ATVBAHA.107. 143552 17561491
12. A synthetic triterpenoid selectively inhibits the induction of matrix metalloproteinases 1 and 13 by inflammatory cytokines. KS Mix JA Mengshol U Benbow MP Vincenti MB Sporn CE Brinckerhoff, Arthritis Rheum 2001 44 1096 1104 10.1002/1529-0131(200105)44:5<1096::AID-ANR1903.0.CO;2-6 11352241
13. Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling. MM Rahman A Bhattacharya G Fernandes, J Lipid Res 2006 47 1739 1748 10.1194/jlr.M600151-JLR200 16702601
14. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. R Newton LM Kuitert M Bergmann IM Adcock PJ Barnes, Biochem Biophys Res Commun 1997 237 28 32 10.1006/bbrc.1997.7064 9266823
15. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. QW Xie Y Kashiwabara C Nathan, J Biol Chem 1994 269 4705 4708 7508926 (Pubitemid 24239438)
16. Adenosine stimulates CREB activation in macrophages via a p38 MAPK-mediated mechanism. ZH Nemeth SJ Leibovich EA Deitch B Sperlagh L Virag ES Vizi C Szabo G Hasko, Biochem Biophys Res Commun 2003 312 883 888 10.1016/j.bbrc.2003.11.006 14651954
17. Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes. RF Schwabe DA Brenner, Am J Physiol Gastrointest Liver Physiol 2002 283 204 211 12065308
18. GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat. L Dugo M Collin DA Allen NS Patel I Bauer EM Mervaala M Louhelainen SJ Foster MM Yaqoob C Thiemermann, Crit Care Med 2005 33 1903 1912 10.1097/01.CCM.0000178350.21839.44 16148458
19. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. M Martin K Rehani RS Jope SM Michalek, Nat Immunol 2005 6 777 784 10.1038/ni1221 16007092
20. beta-Catenin activity negatively regulates bacteria-induced inflammation. Y Duan AP Liao S Kuppireddi Z Ye MJ Ciancio J Sun, Lab Invest 2007 87 613 624 10.1038/labinvest.3700497 17384665
21. Comparison of serum nitric oxide levels in active juvenile rheumatoid arthritis with those of patients in remission. A Beri S Singh A Gupta M Khullar, Rheumatol Int 2004 24 264 266 10.1007/s00296-003-0368-2 14593489
22. Effects of TNFalpha-antagonists on nitric oxide production in human cartilage. K Vuolteenaho T Moilanen M Hamalainen E Moilanen, Osteoarthritis Cartilage 2002 10 327 332 10.1053/joca.2002.0521 11950256
23. Osteoclasts are essential for TNF-alpha-mediated joint destruction. K Redlich S Hayer R Ricci JP David M Tohidast-Akrad G Kollias G Steiner JS Smolen EF Wagner G Schett, J Clin Invest 2002 110 1419 1427 12438440
24. The differential effects of IL-1 and TNF-alpha on proinflammatory cytokine and matrix metalloproteinase expression in human chondrosarcoma cells. J Shi E Schmitt-Talbot DA DiMattia RG Dullea, Inflamm Res 2004 53 377 389 10.1007/s00011-004-1271-3 15316669
25. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. PG Mitchell HA Magna LM Reeves LL Lopresti-Morrow SA Yocum PJ Rosner KF Geoghegan JE Hambor, J Clin Invest 1996 97 761 768 10.1172/JCI118475 8609233
26. IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways. JA Mengshol MP Vincenti CE Brinckerhoff, Nucleic Acids Res 2001 29 4361 4372 10.1093/nar/29.21.4361 11691923
27. The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty-five years of disease. JT Sharp F Wolfe DM Mitchell DA Bloch, Arthritis Rheum 1991 34 660 668 10.1002/art.1780340606 2053913
28. Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. RT Paniagua O Sharpe PP Ho SM Chan A Chang JP Higgins BH Tomooka FM Thomas JJ Song SB Goodman, et al. J Clin Invest 2006 116 2633 2642 16981009
29. A quantitative analysis of kinase inhibitor selectivity. MW Karaman S Herrgard DK Treiber P Gallant CE Atteridge BT Campbell KW Chan P Ciceri MI Davis PT Edeen, et al. Nat Biotechnol 2008 26 127 132 10.1038/nbt1358 18183025